Abstract:Tumors pose a significant threat to human health, and their occurrence and fatality rates are on the rise each year. Accurate tumor diagnosis is crucial in preventing untimely treatment and late-stage metastasis, thereby reducing mortality. To address this, we have developed a novel type of hybrid nanogels called γ-Fe2O3@PNIPAM/PAm/CTS, which contain iron oxide nanoparticles and poly(N-isopropyl acrylamide)/poly(acrylamide)/chitosan. The rational for this study relies on the concept that thermosensitive PNIPAM has the ability to contract when exposed to the elevated temperature conditions found within tumors. This contraction leads to a dense clustering of the high-loading γ-Fe2O3 nanoparticles within the nanogel, thus greatly enhancing the capabilities of MRI imaging. Additionally, the amino groups in chitosan on the particle surface can be converted into ammonium salts under mildly acidic conditions, allowing for an increase in the charge of the nanogel specifically at the slightly acidic tumor site. Consequently, it promotes the phagocytosis of tumor cells and effectively enhances the accumulation and retention of nanogels at the tumor site. The synthesis of the hybrid nanogels involves a surfactant-free emulsion copolymerization process, where vinyl-modified γ-Fe2O3 superparamagnetic nanoparticles are copolymerized with the monomers in the presence of chitosan. We have optimized various reaction parameters to achieve a high loading content of the superparamagnetic nanoparticles, reaching up to 60%. The achieved r2 value of 517.74 mM-1S-1 significantly surpasses that of the clinical imaging contrast agent Resovist (approximately 151 mM-1S-1). To assess the performance of these magnetic nanogels, we conducted experiments using Cal27 oral tumors and 4T1 breast tumors in animal models. The nanogels exhibited temperature- and pH-sensitivity, enabling magnetic targeting and enhancing diagnosis through MRI imaging. The results demonstrated the potential of these hybrid nanogels as contrast agents for magnetic targeting in biomedical applications.

One-Component Supramolecular Filament Hydrogels as Theranostic Label-Free Magnetic Resonance Imaging Agents

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents

Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents

Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.

Stimuli-responsive Biodegradable and Gadolinium-Based Poly[n-(2-hydroxypropyl) Methacrylamide] Copolymers: Their Potential As Targeting and Safe Magnetic Resonance Imaging Probes

Metal-Drug-Protein Assemblies: Gd3+ Self-Enhanced Magnetic Resonance Imaging, High-Sensitive Tumor-Targeting Imaging and Efficient Chemo-Phototherapy

On-demand Degradable Magnetic Resonance Imaging Nanoprobes.

Gadolinium-conjugated folate-poly(ethylene glycol)-polyamidoamine dendrimer-carboxyl nanoparticles as potential tumor-targeted, circulation-prolonged macromolecular magnetic resonance imaging contrast agents. II

Enhancing MRI imaging through high loading of superparamagnetic nanogels with high sensitivity to the tumor environment

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Nonclustered magnetite nanoparticle encapsulated biodegradable polymeric micelles with enhanced properties for in vivo tumor imaging

Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.

Biomass-Derived Organonanomaterials As Contrast Agents for Efficient Magnetic Resonance Imaging

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Magnetic Resonance Imaging-Visible and Ph-Sensitive Polymeric Micelles for Tumor Targeted Drug Delivery

Fabrication and Evaluation of Tumor-Targeted Positive MRI Contrast Agent Based on Ultrasmall MnO Nanoparticles.

A Tailored Nanosheet Decorated with a Metallized Dendrimer for Angiography and Magnetic Resonance Imaging-Guided Combined Chemotherapy

Water-dispersible Multiwalled Carbon Nanotube/iron Oxide Hybrids As Contrast Agents for Cellular Magnetic Resonance Imaging

Amphiphilic block polymer-gadolinium conjugates: Design, synthesis and application as efficient and safe nanoscale magnetic resonance imaging contrast agents

Gadolinium‐conjugated FA‐PEG‐PAMAM‐COOH Nanoparticles As Potential Tumor‐targeted Circulation‐prolonged Macromolecular MRI Contrast Agents

One-pot Synthesis of PEGylated Gd-based Nanoparticles As High-performance and Biocompatibility Contrast Agents for T1-Weighted Magnetic Resonance Imaging in Vivo